Data / Form D filings / DMC Biotechnologies, Inc.
DMC Biotechnologies, Inc.: Form D filings
DMC Biotechnologies, Inc., a biotechnology company in Boulder, CO, filed 9 Form D notices with the SEC between 2018 and 2025. The latest, on December 30, 2025, reports $1.4 million sold of a $2.5 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2477 55TH STREET, SUITE 120, Boulder, CO, 80301
- Phone
- (720) 239-7239
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1728411
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 30, 2025 | New notice | $2,500,000 | $1,414,267 | $1,085,733 | 7 | Dec 16, 2025 | sec.gov |
| Dec 30, 2025 | New notice | $1,658,250 | $904,500 | $753,750 | 4 | Oct 31, 2025 | sec.gov |
| Apr 23, 2025 | New notice | $10,000,000 | $4,791,203 | $5,208,797 | 9 | Apr 8, 2025 | sec.gov |
| Aug 24, 2022 | New notice | $66,720 | $66,720 | 1 | Aug 11, 2022 | sec.gov | |
| Dec 10, 2021 | New notice | $43,500,000 | $33,760,493 | $9,739,507 | 12 | Nov 30, 2021 | sec.gov |
| Jan 28, 2021 | New notice | $22,446 | $22,446 | 1 | Jan 14, 2021 | sec.gov | |
| Jun 27, 2019 | New notice | $12,000,000 | $4,649,995 | $7,350,005 | 3 | Jun 18, 2019 | sec.gov |
| Mar 15, 2019 | Amendment | $2,537,660 | $2,537,660 | 3 | Jan 4, 2018 | sec.gov | |
| Jan 18, 2018 | New notice | $2,499,999 | $1,166,666 | $1,333,333 | 1 | Jan 4, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Josh Yelen | Executive Officer | |
| Josko Bobanovic | Director | |
| Rob van der Meij | Director | |
| K'Lynne Johnson | Director | |
| Alastair Cooper | Director | |
| Jim Flatt | Executive Officer, Director | |
| Doug Cameron | Director | |
| Matthew Lipscomb | Director |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Dec 29, 2025 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what DMC Biotechnologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.